Group One Trading’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09K Buy
+253
New +$1.07K ﹤0.01% 7132
2025
Q3
– Sell
-7,577
Closed -$45K – 8875
2025
Q2
$40.2K Buy
7,577
+6,585
+664% +$38.9K ﹤0.01% 5754
2025
Q1
$8.8K Buy
+992
New +$11.9K ﹤0.01% 6344
2023
Q4
– Sell
-4,055
Closed -$70.2K – 7891
2023
Q3
$65K Sell
4,055
-11,541
-74% -$220K ﹤0.01% 4856
2023
Q2
$362K Buy
15,596
+10,199
+189% +$223K ﹤0.01% 3355
2023
Q1
$125K Buy
+5,397
New +$110K ﹤0.01% 4096
2022
Q3
– Sell
-303
Closed -$6K – 7989
2022
Q2
$6K Hold
303
– – ﹤0.01% 7005
2022
Q1
$8K Buy
+303
New +$7.75K ﹤0.01% 7251
2021
Q4
– Sell
-3,043
Closed -$88.2K – 8625
2021
Q3
$98K Buy
3,043
+2,900
+2,028% +$96.3K ﹤0.01% 5934
2021
Q2
$4K Buy
+143
New +$4.13K ﹤0.01% 7824
2020
Q4
– Sell
-28,697
Closed -$463K – 6816
2020
Q3
$374K Sell
28,697
-700
-2% -$8.86K ﹤0.01% 3106
2020
Q2
$333K Buy
29,397
+24,047
+449% +$341K ﹤0.01% 2951
2020
Q1
$77K Sell
5,350
-7,500
-58% -$158K ﹤0.01% 3471
2019
Q4
$350K Buy
12,850
+1,438
+13% +$39.6K ﹤0.01% 2730
2019
Q3
$327K Buy
11,412
+9,421
+473% +$275K ﹤0.01% 2698
2019
Q2
$55K Buy
+1,991
New +$56.2K ﹤0.01% 3723
2019
Q1
– Sell
-2,425
Closed -$70K – 5163
2018
Q4
$70K Sell
2,425
-579
-19% -$20.8K ﹤0.01% 3377
2018
Q3
$138K Sell
3,004
-3,954
-57% -$176K ﹤0.01% 3285
2018
Q2
$260K Sell
6,958
-12,517
-64% -$423K ﹤0.01% 2845
2018
Q1
$575K Sell
19,475
-9,898
-34% -$335K 0.01% 1948
2017
Q4
$1.01M Buy
29,373
+28,951
+6,860% +$977K 0.01% 1692
2017
Q3
$15K Sell
422
-31,478
-99% -$898K ﹤0.01% 4173
2017
Q2
$824K Buy
31,900
+23,532
+281% +$500K 0.01% 1608
2017
Q1
$161K Sell
8,368
-1,545
-16% -$27.4K ﹤0.01% 2675
2016
Q4
$165K Sell
9,913
-2,419
-20% -$43.8K ﹤0.01% 2553
2016
Q3
$254K Sell
12,332
-4,195
-25% -$106K ﹤0.01% 2298
2016
Q2
$506K Buy
+16,527
New +$574K 0.01% 1727
2015
Q3
– Sell
-27,455
Closed -$974K – 5063
2015
Q2
$933K Sell
27,455
-26,030
-49% -$885K 0.01% 1265
2015
Q1
$1.89M Buy
+53,485
New +$1.91M 0.03% 671
2014
Q4
– Sell
-2,888
Closed -$102K – 5133
2014
Q3
$111K Buy
+2,888
New +$108K ﹤0.01% 2886

Other funds holding MYGN

Group One Trading's MYGN Position: Q3 2026 in Review

Group One Trading opened a new position in Myriad Genetics (MYGN) in Q3 2026: 253 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #7132 among its holdings. This is a return to the name: Group One Trading previously reported a position in MYGN as recently as Q2 2025.

Group One Trading first reported a position in MYGN in Q3 2014 and has held it in 30 quarters since. The position peaked at $1.89M in Q1 2015. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Group One Trading held 253 shares of Myriad Genetics worth $1.09K as of Q3 2026.
  • Myriad Genetics was a new Group One Trading position in Q3 2026.
  • Myriad Genetics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7132 holding.
  • Group One Trading first reported a position in Myriad Genetics in Q3 2014 and has held it in 30 quarters since.
  • Group One Trading's Myriad Genetics position peaked at $1.89M in Q1 2015.
  • 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.